US FDA Drops Plan To Simplify Pharmaceutical Plant Reporting
Executive Summary
Industry complained draft guidance would have made manufacturing establishment information harder to report, not easier.
You may also be interested in...
Accenture Sees AI Solutions For IDMP Compliance, Trial Efficiency
AI could help companies comply with regulations like GDPR and IDMP, apart from optimizing clinical trial processes, Accenture’s managing director leading R&D analytics in North America says, as he lists cases where the firm drove cost savings.
FDA Guidance Clarifies Facility Requirements
The US FDA has made a renewed effort to clarify the types of manufacturing facilities that need to be listed on the Form FDA 356h and Module 3 of the CTD in submissions. Often reviewers find this information missing, which can result in a refuse to file action.
US FDA Details Facilities That NDAs, ANDAs Should Note
The US FDA has made a renewed effort to clarify the types of manufacturing facilities that need to be listed on the Form FDA 356h and Module 3 of the CTD in submissions. Often reviewers find this information missing, whicn can result in a refuse to file action.